Home LiteratureArticle Details
PMID: 21248772 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Loss of E2F7 expression is an early event in squamous differentiation and causes derepression of the key differentiation activator Sp1.

The Journal of investigative dermatology ·Vol. 131 ·No. 5 ·2011-05-00 ·Pages 1077-84

Hazar-Rethinam M, Cameron SR, Dahler AL, Endo-Munoz LB, Smith L, Rickwood D, Saunders NA

Abstract

Squamous differentiation is controlled by key transcription factors such as Sp1 and E2F. We have previously shown that E2F1 can suppress transcription of the differentiation-specific gene, transglutaminase type 1 (TG1), by an indirect mechanism mediated by Sp1. Transient transfection of E2F1-E2F6 indicated that E2F-mediated reduction of Sp1 transcription was not responsible for E2F-mediated suppression of squamous differentiation. However, we found that E2F4 and E2F7, but not E2Fs 1, 2, 3, 5, or 6, could suppress the activation of the Sp1 promoter in differentiated keratinocytes (KCs). E2F4-mediated suppression could not be antagonized by E2Fs 1, 2, 3, 5, or 6 and was localized to a region of the human Sp1 promoter spanning -139 to + 35 bp. Chromatin immunoprecipitation analysis, as well as transient overexpression and short hairpin RNA knockdown experiments indicate that E2F7 binds to a unique binding site located between -139 and -119 bp of the Sp1 promoter, and knockdown of E2F7 in proliferating KCs leads to a derepression of Sp1 expression and the induction of TG1. In contrast, E2F4 knockdown in proliferating KCs did not alter Sp1 expression. These data indicate that loss of E2F7 during the initiation of differentiation leads to the derepression of Sp1 and subsequent transcription of differentiation-specific genes such as TG1.

MeSH Terms
Cell Differentiation/genetics Cells, Cultured E2F7 Transcription Factor/genetics,metabolism Gene Expression Regulation, Enzymologic Humans Keratinocytes/cytology,metabolism Promoter Regions, Genetic Sp1 Transcription Factor/genetics,metabolism Transglutaminases/genetics
Chemicals
E2F7 Transcription Factor E2F7 protein, human Sp1 Transcription Factor Transglutaminases transglutaminase 1
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Hazar-Rethinam Mehlika
Epithelial Pathobiology Group, Diamantina Institute, Princess Alexandra Hospital, University of Queensland, Brisbane, Queensland, Australia.
Cameron Sarina R
Dahler Alison L
Endo-Munoz Liliana B
Smith Louise
Rickwood Danny
Saunders Nicholas A
Article Info
Journal
The Journal of investigative dermatology
Abbr.
J Invest Dermatol
ISSN
1523-1747
Published
2011-05-00
Epub
2011-00-20
Pages
1077-84
Language
English
Region
United States
NLM ID
0426720
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com